Angiographically Documented Macular Ischemia after Single Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion
Yonsei Medical Journal
;
: 676-678, 2017.
Article
in English
| WPRIM
| ID: wpr-124971
ABSTRACT
This report describes a case of angiographically documented foveal avascular zone (FAZ) enlargement after a single intravitreal injection of bevacizumab for macular edema secondary to central retinal vein occlusion (CRVO). A 71-year-old female was treated with an intravitreal bevacizumab injection for macular edema following CRVO. Despite successfully decreased edema one month after injection, the postinjection best-corrected visual acuity immediately decreased from 20/40 to 20/1000 (Snellen equivalent). The FAZ area increased from 0.37 mm² to 3.11 mm² (8.4-fold increase). While intravitreal anti-vascular endothelial growth factor is effective and should be considered as a first-line treatment for macular edema secondary to CRVO, it may aggravate macular ischemia.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Retinal Vein
/
Fluorescein Angiography
/
Visual Acuity
/
Macular Edema
/
Endothelial Growth Factors
/
Edema
/
Intravitreal Injections
/
Bevacizumab
/
Fovea Centralis
/
Ischemia
Limits:
Aged
/
Female
/
Humans
Language:
English
Journal:
Yonsei Medical Journal
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS